Human peroxisome proliferator-activated receptor alpha (hPPARa) is a ligand-dependent transcription factor that mainly controls lipid metabolism in the liver. It has drawn wide attention as a significant target for developing new hypoglycaemic drugs. However, a central and largely unresolved question in finding new drugs targeted on hPPARa concerns ligand action mechanism: what makes certain molecules act as antagonists while others behave as agonists in the same binding site? To understand this, we performed a total of 600 ns all-atom molecular dynamics (MD) simulations to explore how four small molecule ligands bind to the hPPARa and play opposite effects. We characterized and compared the protein backbone fluctuation, and investigated the interaction networks and the movements of helixes and loops near binding site during MD simulations.
Introduction
Peroxisome proliferator activated receptors (PPARs) are nuclear receptors that function as transcription factors mediating gene expression. [1] [2] [3] [4] [5] [6] There are three distinct PPAR subtypes, termed as PPARa, PPARb/d and PPARg. Among these receptors, hPPARa has been the most broadly researched, because it plays important roles in regulating glucose, cholesterol and lipids metabolism as well as in the fatty acid b-oxidation and homeostasis. 7 These make hPPARa as an important pharmacological target for the discovery of novel therapeutic agents used for treatment of dyslipidemia and type 2 diabetes mellitus (T2DM). 8, 9 The increasing data collected by several experimental techniques, including uorescence anisotropy, NMR and X-ray crystal, together with related computer simulations of PPARs have resolved many key features of structures in the activation approach of PPARs, including molecular switch, ligand-binding specicity and interactions with regualtors. 7, [10] [11] [12] [13] Despite this progress, lots of important mechanistic principles of hPPARa mediating signal transduction are still poorly understood at the molecular level. For example, how can drugs that bind to the same regions of the hPPARa exert opposite responses? Molecular dynamics (MD) simulation could be an important tool to help to solve this issue.
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As most available crystal structures concerned about the ligand binding domain (LBD) of hPPARa, we termed hPPARa standing for hPPARa LBD for clear in our study. hPPARa has many agonists and different types of agonists always introduce different effects as Davide Capelli's team reported. 15 In this work, we focused on these agonists that bind into the classic ligand binding pocket (LBP) of hPPARa and directly interact with Helix-12. To address mechanistic and structural questions about hPPARa, four complexes as shown in Fig. S1 (see ESI †), hPPARa-YIN, hPPARa-13M and hPPARa-NKS for agonist-bound conformation (PDB: 4CI4, 3VI8 and 3KDU) and hPPARa-471 for antagonist-bound conformation (PDB: 1KKQ) in which 471 is the only one for antagonizing hPPARa in PDB database, were subjected to perform all-atom MD simulations with three parallel runs. Then, the uctuation of protein backbone, the residue community networks as well as the movements of helices and loops during these MD simulations were characterized respectively. As a result, we discovered that the interaction change of H2 0 -H3 loop and H11-H12 loop directly induced H12 conformation change during MD simulations. In addition, by energy calculation, 11 hotspots for the four different ligands binding hPPARa complexes and some other key residues causing for hPPARa's activation conformation change were identied. These results could help understand the mechanism of hPPARa activation and design new drugs targeted on hPPARa.
Methods

Preparation for MD
The antagonist-bound structure of hPPARa LBD was solved in complex with 471 (PDB: 1KKQ) at 3.0Å resolution, 16 in which the co-suppressor peptide was removed, and three agonistbound systems were determined in complexes with agonist Y1N (PDB: 4CI4) at 2.3Å, 7 agonist 13M (PDB: 3vi8) at 1.75Å and agonist NKS (PDB: 3KDU) at 2.07Å. The sequence of hPPARa LBD was used from 204 to 467 in these four systems. The missing loops and other missing residues were repaired by using Prime module of Schrodinger suite soware. 17, 18 Crystal water molecules beyond 4Å of complex were deleted. Hydrogen atoms were added by tleap integrated in AmberTools15.
19 All calculation are nished in the house computer workstation based on CPU calculation of Wu's Lab.
MD process
MD simulations of the four hPPARa complexes were carried out using Amber14 suit.
19 Each complex will be simulated three times at different initial speeds (each 50 ns). A total of 600 ns simulation will be run in our research. The FF14SB force eld parameter set was chosen for receptor hPPARa. The electrostatic potential of four ligands was calculated at the B3LYP/6-311G* level using Gaussian 09 D soware. 20 Then, we used the antechamber package 21 to get RESP charge 22 values. The molecular force eld parameters for agonist and antagonist were using with the general amber force eld (GAFF). 23 All agonist bound systems were neutralized by adding 3 Na + ions and antagonist bound system was neutralized by adding 2 Na + ions, then solvated in a truncated octahedron box with TIP3P water molecules. The distance between any atom in hPPARaligand and the edge of the periodic box was set no less than 8Å. The long-range electrostatic interactions were computed with a non-bonded cut-off of 8Å by using Particle Mesh Ewald (PME) method, 24 and the SHAKE algorithm 25 was applied to constrain covalent bonds connecting hydrogen. Energy minimization process used the steepest descent and conjugated gradient methods. 26 Systems gradually heated to 300 K during 200 ps using the Langevin thermostat method with the collision frequency 2 ps À1 , and followed by 50 ps of density equilibration.
Restraints force constant of 2 kcal (molÅ 2 ) À1 were only performed on atoms of receptor-ligand complex in the above ow. Last, all systems were equilibrated with unconstrained MD simulations for total 50 ns in an isothermal-isobaric (NPT) ensemble. The time step was 2.0 fs. The trajectory coordinates and information were kept every 2 ps for results analysis in MD production state.
Dynamics correlation network construction and community analysis
Correlated atom positional uctuations of residues were characterized with Bio3D packages of R as reported elsewhere.
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The nodes, which were mapped to different colors and scaled variable sizes by the containing number of residues, represented residual groups in network. Edges, which were weighted and colored by constituent atomic correlation values, connect these clusters. Node centrality, suboptimal paths calculation and community analysis were applied to each network to characterize properties of network and identify residues involved in the dynamic coupling of different sites by using Bio3D packages.
Principal components analysis (PCA)
To extract the principal model related to the conformational motions, the collective motions of all systems were investigated by PCA. 31 Translational and rotational motions were removed before the covariance matrix calculation with least-squares superposition to the averaged-structure. The covariance matrix of all Ca atoms' coordinates was calculated with the next equation:
where r i and r j represented to inner coordinates of alpha carbon i and j. PCA was used with R soware and the cpptraj package in AmberTools15. The positional covariance matrixes of Ca atoms were diagonalized to generate the eigenvectors and associated eigenvalues. An eigenvector means a correlated motion of a number of atoms in a multi-dimensional space. While, the eigenvalues were the amplitude of the motion along the corresponding eigenvector.
Binding free energy calculation
The Molecular Mechanics/Generalized Born Surface Area (MM/ GBSA) method 33 was carried out to calculate free energy of binding for macromolecules by combining molecular mechanics calculations and continuum solvation models. Here was applied to compute the binding free energies of ligands. The free energy of binding DG bind was calculated as:
In which DE MM , DG sol and ÀTDS were equivalent to the changes of the gas phase MM energy, the solvation free energy and the conformational entropy on binding. DE MM was standard molecular mechanics term including DE internal (bond, angel and dihedral energies) which would be cancelled as we used a single trajectory approach to reduce the noise, 33 van der Waals interaction DE vdw and electrostatic DE ele energies. The nonpolar solvation free energy DG nonpol was calculated from the area (SASA) using the method of linear combination of pairwise overlaps (LCPO) (DG nonpol ¼ 0.0072 Â DSASA). 34 The SASA here was determined with probe radii of 1.4Å. The electrostatic free energy of solvation DG pol was calculated by the generalized Born method (igb ¼ 5) developed by Onufriev et al. 35 ÀTDS was the conformational entropy change calculated by normal mode analysis on a set of conformational snapshots taken from MD simulation.
36
The DE MM and DG sol calculations were performed using 4000 snapshots striped from the nal 40 ns simulation with an interval of 10 ps. The conformational entropy change upon ligand binding (ÀTDS) was evaluated with the normal-mode analysis using the nmode program in AmberTools15 package. However, because the entropy calculations for larger systems being extremely computationally expensive, merely 200 snapshots were chosen with an interval of 100 ps during equilibrium state of simulation to calculate ÀTDS. All these snapshots were minimized with 50 000 steps by using a distance-dependent dielectric constant (dielc ¼ 1.0) and a root-mean-square gradient (d rms ¼ 1.0 Â 10 À4 kcal mol À1ÅÀ1 ).
Free energy decomposition to ligand-residue interaction
To quantitatively evaluate the contribution to the two ligands' binding, the total, electrostatic, van der Waals interaction and solvation energies between residues of hPPARa and ligands (Agonists: Y1N, 13M and NKS. Antagonist: 471) were computed based on the Amber force eld equation. Each energy component was estimated by using the snapshots from above calculation of DE MM and DG sol .
Phylogenetic tree analysis
Energy contributions of 264 residues to four ligands rendered a 2 dimensional vector. The phylogenetic tree of residues contributing to Y1N, 13M, NKS and 471 in hPPAR-'s LBD was produced with the statistical analysis package R-3.3.1. 37 The Manhattan distance 38 was selected to calculate similarities among vectors:
where i indicated the dimension of the residue's energy contribution x and y. Hierarchical clustering was carried out for minimize the total variance within cluster by ward D2 method 39 in R. Then the result of hierarchical clustering was transformed to a phylogenetic tree which plotted by the latest version of iTOL. 40 The residues impeded ligands' binding were showed in blue (the highest one was colored as deep blue and the lower one was set to fade gradually to white). While, the residues favoring ligands' binding were colored in red (the one with the highest contribution was colored as deep red and the lower contribution one was set to fade gradually to white). White color here denoted residue with no contribution to ligands' binding.
Results and discussion
Simulation convergence
Starting with the agonist-bound (PDB: 4CI4, 3KDU and 3VI8) and the antagonist-bound (PDB: 1KKQ) structures of hPPARa with ligands kept, sufficiently long simulations should generate converged ensembles. The root mean square deviation (RMSD) of protein backbone atoms (O, C, Ca, N) were calculated referring to the repaired structures (Fig. S2 , green color structures, see ESI †) in preparation of MD and plotted in Fig. 1(A) . The RMSD plot of the backbone atoms for antagonist-bound hPPARa complex (hPPARa-471) displayed a signicant degree of structural variation comparing to agonist-bound hPPARa complexes (hPPARa-Y1N, hPPARa-13M and hPPARa-NKS). As illustrated in Fig. 1(A) , the RMSD values for hPPARa-Y1N, hPPARa-13M and hPPARa-NKS complexes uctuate around 1.6, 1.7 and 1.5Å in the period of 10-50 ns respectively, while the values for hPPARa-471 complex stabilize at about 2.7Å comparing initial structure aer 10 ns. Moreover, we aligned the conformation every 5 ns and the original crystal structure for these four systems as showed in Fig. S2 (see ESI †) . As the original co-suppressor removed in hPPARa-471 for better comparing with the agonist-bound hPPARa complexes (hPPARa-Y1N, hPPARa-13M and hPPARa-NKS), H12 changed its conformation to parallel with H3 aer the rst 2 ns (the video part) and kept this conformation in the rest time. All these data indicated that these four systems had been reached equilibrium state aer rst 10 ns.
The root mean square uctuation (RMSF), which is another useful method to study the stability of systems, reects the mobility of certain amino acid residues around their average positions. Fig. 1(B) illustrates the difference of residue exibility among the four systems. The peaks in the RMSF plot stand for magnitudes of residue exibility. Residues 256-266 are obviously more exible in antagonist 471 bounded system in which the RMSF value is above 4Å than in three agonists bounded systems. These residues constructed a loop connecting H2 0 and H3 which are directly involving in building the classic LBP of hPPARa. 41 The exibility change of this loop may relate to hPPARa's ligand recognition and stabilization as Amanda Bernardes' group reported in which they named the loop of residues 256-266 as a part of U-loop. 
Residues communication network analysis
To aid in further interpretation and quantication of residues' motions coupling in agonists (Y1N, 13M, NKS) and antagonist 471 bounded system, we constructed residues communication network using the data from the last 40 ns of the production runs as showed in Fig. 2 . In the four correlation network plots as displayed in Fig. 2(A) -(D) top parts, each node represents a cluster of residues in close interaction, while the color and the thickness of each connecting edge is weighted and colored by the correlation value between the two clusters. This method has been used successfully to discover motional couplings of residues in many systems. 27, 42, 43 In agonist-bound hPPARa systems ( Fig. 2(A)-(C) ), there were more nodes than in the antagonistbound system: 10 nodes were found in hPPARa-Y1N, and 9 nodes were found in both hPPARa-13M and hPPARa-NKS, while only 7 nodes were observed in hPPARa-471. Nodes size and ID number were listed in Table S1 (see ESI †).
There were fewer larger nodes in agonist systems than in antagonist system because several smaller nodes had merged aer antagonist binding. This nding indicated that there were more discrete local interactions in the active state of the receptor. Specically, the position of H11-H12 loop (residues 450-456) in the surface region varied with the state of the receptor, leading to a different interaction network. Among antagonist-bound systems, the loop shared the same community network with the head part of H3 which interacting with this loop both colored in yellow as showed in Fig. 2(D) bottom, this interaction related to that inducing H12 to move away from H11 and pack against H3 as an inactive conformation, as H11-H12 loop connected the H12. These ndings were in agreement with the experiment result. 16 Moreover, the coupling between the head part of H3 and H11-H12 loop disrupted the interaction between H2 0 -H3 loop (residues 255-256) and H11-H12 loop in 471 bounded system, which was identied by less residues contact (Table S2 , see ESI †) and further mass center distance (Fig. S7 , see ESI †) between H2 0 -H3 loop and H11-H12 loop comparing in the three agonists bound systems. As a result, the increasing uctuation of residues 256-266 was detected in above RMSF of 471 bounded system.
Detecting signicant conformational differences from principal component analysis (PCA)
To better understand the complicated conformational motions which may be relevant to the mechanism of hPPARa's activation in the three agonists bounded hPPARa systems and deactivation in hPPARa-471 system, principal component analysis was implemented. For clearly, we rstly comparing the hPPARa-471 and hPPARa-Y1N systems. Fig. 3(A) shows the eigenvalues at the very beginning are relative to larger concerted motions, but decrease quickly and reach more localized uctuations. These results suggest that the top 20 principal components (PC) could capture 71.9% and 71.1% of total variance during the last 40 ns of the trajectories in 471 and Y1N bounded systems, respectively. Similarly, top 20 PCs could capture 75.4% and 73.3% of total variance in 13M and NKS bounded systems as showed in (see ESI †). The conformational behavior of the two systems, which was projected along the direction of PC1 and PC2, showed difference as plotted in Fig. 3(B) and (C). In order to nd the way in which agonist Y1N or antagonist 471 affected the motions described by this two PCs, we calculated the displacements of PC1 and PC2 of the two complexes. The motions of residues 256-266 (located in the loop behind H2 0 ) in antagonist 471 Fig. 4 The different forms of H2 0 -H3 loop based on the last frame. The H2 0 -H3 loop colored in red and others residues colored in pink within 5Å in hPPARa-Y1N system. The H2 0 -H3 loop colored in blue and others residues colored in marine blue within 5Å in hPPARa-471 system. bounded system were obviously higher than Y1N bounded system as described in both Fig. 3(D) and (E). Similarly, both agonists 13M and NKS bounded systems also presented lower values comparing hPPARa-471 from PC1 and PC2 in the peak of residues 256-266 as displayed in Fig. S3(D) and (E) (see ESI †). These results were consistent with the RMSF results and suggested that the H2 0 -H3 loop was more stable in agonists bounded systems. Detailly, residues 256-266 could interacted with H3 and H11-H12 loop (residues 450-456) by a closed loop form in hPPARa-Y1N (Fig. 4, red loop) . We also found the similar phenomenon to hPPARa-13M and hPPARa-NKS as displayed in Fig. S4 (see ESI †) . While, H2 0 -H3 loop (residues 256-266) adopted open form (Fig. 4 , blue loop) only interacting with H2 0 and small part of H3 head in hPPARa-471 system. As the interaction decreased, which was also identied by the loop contact information in Tables S2 and  S3 (see ESI †), the uctuation of this loop (residues 256-266) increased signicantly (Fig. S3(D) and (E) †). On the other hand, the region about residues 414-424 showed different behaviors along PC1 and PC2. It reversed in Fig. 3(D) and (E), while it almost had no peak in hPPARa-NKS (Fig. S3(D) and (E) †). However, the global effect of this region was similar as identied in above RMSF when all results of PCs accumulated.
Analysis of the binding energy
In order to explore the effects caused by the agonist or antagonist on the interaction between hPPARa and ligands, we calculated the individual energy components and the binding free energies by Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) calculation. 
Phylogenetic tree analysis based on energy decomposition
To overall characterize the residues contribution to the interaction between receptor and ligands, a phylogenetic tree, in which ward algorithm was chosen in hierarchical clustering procedure, was used to identify hot spots from 264 residues based on per-residue MM/GBSA free energy decomposition. In Fig. 5 , four groups of residues were found. Residues favoring ligands binding were colored in red. The residue with the highest contribution (À4.764 kcal mol À1 ) was colored as deep red. The color of the lower contribution was set to fade gradually towards white (almost no contribution). While, the residues obstructing ligand binding were displayed in blue. The highest one was colored as deep blue (0.722 kcal mol À1 ) and the color of the lower was set to fade gradually towards white. Notably, the residue with the most favoring ligand binding energy is much bigger than the most obstructing the binding. As shown in Fig. 5 , energy contribution of group A (MET355, PHE273, CYS276, MET330, ILE272, VAL332, PHE318, ILE339, HIE440, ILE354, CYS275) were consistently higher for four ligands than that group B, C and D, suggesting group A playing a crucial role to bound ligands. Actually, the residues of group A directly construct the ligand pocket 7, 16 as displayed in Fig. S1 (see ESI †), and the sum of group A's energy contributions accounted for the major part of the total energy (65.52% for Y1N, 54.05% for 471, 51.80% for 13M and 50.80% for NKS). Except HIE440, the rest 10 residues were all hydrophobic amino acids. Those 11 residues revealed a similar pattern in ligand binding which ligands must have a suitable hydrophobic group to t, and were identied as hot spots for hPPARa's binding. Moreover, the residue CYS276 of H3 showed deepest red (À2.70, À3.41, À4.15 and À4.76 kcal mol À1 for binding Y1N, 471, 13M and NKS respectively) in four systems, indicating that it playing an important role and favoring binding interaction for both agonists (Y1N, 13M, NKS) and antagonist (471). But the interaction modes of these four ligands with CYS276 were different, in which Y1N and 13M adopting L-shaped conguration contacted with this residue, while NKS and 471 wrapped CYS276 liking U-shaped as displayed in Fig. S5 (see ESI †). Based on this information, CYS276 may be a hot site for developing new covalent drugs, as its side chain orientation, close distance to ligand (Fig. S6 , see ESI †) and nucleophilic property. 44, 45 In spite of weak contributions or weak against to binding interaction in cluster C and D, some residues display almost opposite characteristics which were also essential for conformation change with ligand binding. For example, the side chain of residue SER280 (À0.42, À0.66 and À0.46 kcal mol À1 for Y1N, 13M and NKS respectively, as displayed in Fig. S8-S10 , see ESI †) formed a hydrogen bond with carboxyl of each agonist in these three agonist-bounded hPPARa systems (Fig. S11(A) , S11(C) and S11(D), see ESI †), while it (about 0.08 kcal mol À1 ) contacted with the hydrophobic fragment of benzene in antagonist 471 (Fig. S11(B) , see ESI †). Similarly, VAL437 and ILE447 in antagonist system (À0.37 kcal mol À1 and À0.62 kcal mol
À1
, as displayed in Fig. S8 , see ESI †) favored binding the hydrophobic fragment of 471, which was plotting with sphere in Fig. S11(B) (see ESI †), comparing in these three agonist-bounded hPPARa systems hPPARa-Y1N, hPPARa-13M and hPPARa-NKS (VAL437: 0.015, 0.049 and 0.035 kcal mol
; ILE447: 0.025, 0.072 and 0.185 kcal mol À1 in Fig. S8 -S10, see ESI †). As this hydrophobic interaction existed, H12, where the side chain position of residue TYR464 was occupied by the hydrophobic fragment of 471 plotted in sphere (Fig. 6) , were pushed away from H11 to pack against H3. These calculations were consistent with H. Eric Xu's group experiment results. 16 Together, these 11 hotspots are essential for the agonists Y1N, 13M and 471, or antagonist 471 binding in the pocket of hPPARa, but these residues with reverse affinity may directly decide the conformation of hPPARa to agonist or antagonist.
Conclusions
MD simulations enable us to visualize the molecular motion with time evolution. In this study, multiple computational methods were integrated to explore the molecular activation mechanism of hPPARa. We found that both antagonist 471 and three agonists (Y1N, 13M and NKS) are favoring with the same 11 residues analyzed in a phylogenetic tree. These 11 hotspots made ligand binding stable, while the binding interaction induced other residues conformation change to t the ligand. These residues, like SER280, VAL437, ILE447 and TYR464, had a lower contribution for binding ligand comparing 11 hotspots, but were directly involved in inducing receptor conformation change during ligand binding. In the inactive conformation of hPPARa, ILE437 and ILE447 interacted with 471's larger head group, which occupied the space of TYR464 and pushed the H12 packing against H3. As conformation change of H12 decreased the contact between H11-H12 loop and H2 0 -H3 loop, H11-H12 loop changed motion to coupling with the head part of H3 identied in the residue communication network. Residues 256-266 of H2 0 -H3 loop were detected more variable in both RMSF and PCA analysis comparing in active stage of the receptor. Finally, based on these series of changes, hPPARa presented active or inactive conformation to t these three agonists (Y1N, 13M and NKS) or antagonist 471. All these ndings provide new insights into the molecular changes and fundamental mechanism of receptor activation. Such insights are help for understanding the activation of hPPARa in the atom level and are valuable guidance for hPPARa targeted drug design.
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